HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lloyd A Horrocks Selected Research

Phospholipases A2 (Phospholipase A2)

10/2007The roles of NADPH oxidase and phospholipases A2 in oxidative and inflammatory responses in neurodegenerative diseases.
9/2006Inhibitors of brain phospholipase A2 activity: their neuropharmacological effects and therapeutic importance for the treatment of neurologic disorders.
11/2004Biochemical aspects of neurodegeneration in human brain: involvement of neural membrane phospholipids and phospholipases A2.
9/2004Brain phospholipases A2: a perspective on the history.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lloyd A Horrocks Research Topics

Disease

7Nervous System Diseases (Neurological Disorders)
12/2007 - 01/2003
6Alzheimer Disease (Alzheimer's Disease)
10/2007 - 04/2004
6Neurodegenerative Diseases (Neurodegenerative Disease)
10/2007 - 03/2004
5Inflammation (Inflammations)
12/2007 - 03/2004
5Neuroinflammatory Diseases
12/2007 - 09/2004
2Pathologic Processes
10/2007 - 06/2006
2Wounds and Injuries (Trauma)
05/2007 - 11/2004
2Ischemia
09/2006 - 09/2006
2Spinal Cord Ischemia
09/2006 - 11/2004
2Epilepsy (Aura)
09/2006 - 09/2006
2Schizophrenia (Dementia Praecox)
07/2004 - 04/2004
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
12/2007
1Brain Ischemia (Cerebral Ischemia)
10/2007
1Parkinson Disease (Parkinson's Disease)
09/2006
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
09/2006
1Multiple Sclerosis
09/2006
1Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease)
09/2006
1Prion Diseases (Transmissible Spongiform Encephalopathies)
09/2006
1Neuroblastoma
09/2005
1Necrosis
11/2004
1Craniocerebral Trauma (Head Injury)
11/2004
1Peroxisomal Disorders (Peroxisomal Disorder)
04/2004

Drug/Important Bio-Agent (IBA)

5LipidsIBA
12/2007 - 09/2004
4Docosahexaenoic AcidsIBA
12/2007 - 01/2003
4Phospholipases A2 (Phospholipase A2)IBA
10/2007 - 09/2004
2EnzymesIBA
10/2007 - 04/2004
2CytokinesIBA
05/2007 - 09/2006
2Lipid PeroxidesIBA
09/2006 - 11/2004
2Anti-Inflammatory Agents (Anti-Inflammatories)IBA
09/2006 - 03/2004
2Phospholipids (Phosphatides)FDA LinkGeneric
09/2006 - 11/2004
2Phospholipases (Phospholipase)IBA
09/2006 - 07/2004
1Eicosapentaenoic AcidIBA
12/2007
1AntioxidantsIBA
12/2007
1Fish OilsIBA
12/2007
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
12/2007
1AnionsIBA
10/2007
1NADPH Oxidases (NAD(P)H oxidase)IBA
10/2007
1Superoxides (Superoxide)IBA
10/2007
1Glycerophospholipids (Phosphoglycerides)IBA
07/2007
1SphingolipidsIBA
07/2007
1ProstaglandinsIBA
05/2007
1ThromboxanesIBA
05/2007
1Transcription Factors (Transcription Factor)IBA
05/2007
1LipoxinsIBA
05/2007
1Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA
05/2007
1LeukotrienesIBA
05/2007
1Phospholipases AIBA
09/2006
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
09/2006
1Neuroprotective AgentsIBA
09/2006
1LipoxygenasesIBA
09/2006
11-dodecylpyridoxal (PLD)IBA
09/2005
1CalciumIBA
11/2004
1RetinoidsIBA
07/2004
1Ion Channels (Ion Channel)IBA
04/2004
1Antimalarials (Antimalarial Agents)IBA
03/2004
1Neurotransmitter Agents (Neurotransmitter)IBA
03/2004
1PlasmalogensIBA
01/2003